@Article{,
AUTHOR = {Jack Barkin},
TITLE = {Erectile dysfunction and hypogonadism (low testosterone)},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {18},
YEAR = {2011},
NUMBER = {Suppl.2},
PAGES = {2--7},
URL = {http://www.techscience.com/CJU/v18nSuppl.2/63029},
ISSN = {1488-5581},
ABSTRACT = {Erectile dysfunction (ED) is one of the earliest signs 
and markers of present or potential future endothelial 
dysfunction. One of the causes of ED can be low 
testosterone levels or hypogonadism. This article describes 
ways to identify and diagnose patients with ED or 
hypogonadism, and it offers a plan for treatment of these 
conditions. The mainstay first-line medical therapies 
for ED are phosphodiesterase-5 (PDE-5) inhibitors. For 
patients with symptomatic hypogonadism, testosterone 
replacement therapy is both safe and effective.},
DOI = {}
}